HB Meth 125mg Injection contains Methylprednisolone 125mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. This injectable formulation is indicated for the management of a variety of conditions including severe allergic reactions, autoimmune disorders, inflammatory diseases, and certain endocrine disorders. Methylprednisolone acts by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing inflammation and tissue damage. The injection is typically administered intramuscularly or intravenously under medical supervision, allowing for rapid onset of action in acute settings. Dosage and duration of therapy should be tailored to the individual patient’s condition and response, with careful monitoring to minimize potential adverse effects such as immunosuppression, hyperglycemia, hypertension, and osteoporosis. HB Meth 125mg Injection is contraindicated in patients with systemic fungal infections and should be used with caution in those with diabetes, hypertension, or peptic ulcer disease. It is essential to follow recommended guidelines for tapering the dose to avoid adrenal insufficiency upon discontinuation. This product should be stored according to manufacturer instructions and handled by healthcare professionals trained in corticosteroid administration.